UBS Group’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-89
| Closed | -$46 | – | 10580 |
|
|
2023
Q3 | $46 | Buy |
+89
| New | +$62 | ﹤0.01% | 9020 |
|
|
2023
Q2 | – | Sell |
-6,341
| Closed | -$7.67K | – | 10422 |
|
|
2023
Q1 | $7.67K | Buy |
6,341
+1,814
| +40% | +$1.91K | ﹤0.01% | 7785 |
|
|
2022
Q4 | $3.76K | Sell |
4,527
-791
| -15% | -$884 | ﹤0.01% | 9455 |
|
|
2022
Q3 | $7K | Buy |
+5,318
| New | +$12K | ﹤0.01% | 8977 |
|
|
2022
Q2 | – | Sell |
-4,852
| Closed | -$24K | – | 11665 |
|
|
2022
Q1 | $24K | Buy |
4,852
+3,120
| +180% | +$15.8K | ﹤0.01% | 7272 |
|
|
2021
Q4 | $11K | Buy |
+1,732
| New | +$19.8K | ﹤0.01% | 8733 |
|
|
2021
Q3 | – | Sell |
-405
| Closed | -$9K | – | 10566 |
|
|
2021
Q2 | $9K | Buy |
405
+283
| +232% | +$5.87K | ﹤0.01% | 8197 |
|
|
2021
Q1 | $3K | Buy |
+122
| New | +$3.06K | ﹤0.01% | 8570 |
|
|
2020
Q3 | – | Sell |
-105
| Closed | -$8K | – | 8629 |
|
|
2020
Q2 | $8K | Sell |
105
-266
| -72% | -$22.3K | ﹤0.01% | 7176 |
|
|
2020
Q1 | $23K | Buy |
371
+181
| +95% | +$14.1K | ﹤0.01% | 6419 |
|
|
2019
Q4 | $15K | Buy |
190
+142
| +296% | +$9.96K | ﹤0.01% | 7074 |
|
|
2019
Q3 | $3K | Buy |
48
+11
| +30% | +$717 | ﹤0.01% | 7685 |
|
|
2019
Q2 | $2K | Sell |
37
-41
| -53% | -$7.12K | ﹤0.01% | 7661 |
|
|
2019
Q1 | $17K | Buy |
78
+32
| +70% | +$12.9K | ﹤0.01% | 6452 |
|
|
2018
Q4 | $16K | Buy |
46
+2
| +5% | +$1.55K | ﹤0.01% | 6965 |
|
|
2018
Q3 | $51K | Buy |
44
+2
| +5% | +$1.84K | ﹤0.01% | 6155 |
|
|
2018
Q2 | $36K | Buy |
42
+5
| +14% | +$4.15K | ﹤0.01% | 6265 |
|
|
2018
Q1 | $44K | Buy |
37
+31
| +517% | +$34.3K | ﹤0.01% | 5816 |
|
|
2017
Q4 | $5K | Sell |
6
-2
| -25% | -$1.85K | ﹤0.01% | 7418 |
|
|
2017
Q3 | $9K | Buy |
+8
| New | +$9.1K | ﹤0.01% | 6967 |
|
|
2017
Q2 | – | Sell |
-13
| Closed | -$16K | – | 8117 |
|
|
2017
Q1 | $16K | Sell |
13
-16
| -55% | -$15.4K | ﹤0.01% | 6325 |
|
|
2016
Q4 | $31K | Buy |
29
+23
| +383% | +$10.4K | ﹤0.01% | 6219 |
|
|
2016
Q3 | $2K | Sell |
6
-18
| -75% | -$7.34K | ﹤0.01% | 7441 |
|
|
2016
Q2 | $10K | Buy |
+24
| New | +$11.8K | ﹤0.01% | 6806 |
|
|
2016
Q1 | – | Sell |
-17
| Closed | -$10K | – | 8381 |
|
|
2015
Q4 | $10K | Buy |
+17
| New | +$11.9K | ﹤0.01% | 7301 |
|
|
2015
Q2 | – | Sell |
-8
| Closed | -$9.38K | – | 8969 |
|
|
2015
Q1 | $12K | Sell |
8
-9
| -53% | -$11.4K | ﹤0.01% | 7511 |
|
|
2014
Q4 | $24K | Buy |
+17
| New | +$24.6K | ﹤0.01% | 7405 |
|
Other funds holding HSTO
UBS Group's HSTO Position: Q4 2023 in Review
UBS Group sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 89 shares — an estimated $46 sold.
UBS Group first reported a position in HSTO in Q4 2014 and held it in 27 quarters. The position peaked at $51K in Q3 2018. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.
- UBS Group reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- UBS Group sold 89 Histogen Inc. Common Stock shares in Q4 2023, an estimated $46.
- UBS Group first reported a position in Histogen Inc. Common Stock in Q4 2014 and held it in 27 quarters.
- UBS Group's Histogen Inc. Common Stock position peaked at $51K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.
Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.